Fate Therapeutics, Inc. vs UnitedHealth Group Incorporated — Stock Comparison

FATE
Fate Therapeutics, Inc.
$1.53
▲ 22.40%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 5.4/10

Q·Score Breakdown

5.4
Bearish
Overall
6.3
Neutral
1.6
Quality
6.2
9.7
Health
5.3
4.7
Growth
5.1
6.5
Valuation
7.3
5.2
Sentiment
8.1
FATE

Clean balance sheet with low leverage (0.4× debt-to-equity).

low return on equity (-52%).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

HOLD
Target $5.19 (+239.1%)
8 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

FATE
UNH
Trailing P/E
27.9×
-1.5×
Forward P/E
17.8×
0.0%
Profit Margin
2.7%
0.0%
Gross Margin
18.8%
-51.8%
ROE
12.2%
-26.4%
Revenue Growth
2.0%
Earnings Growth
0.7%
2.24
Beta
0.41
Price / Book
$178M
Market Cap
$334.9B
$1 – $2
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →